PKM and dermatomyositis: We further illustrate the clinical relevance of PKM2 and IF1, two proteins that respectively act on glycolysis and oxidative phosphorylation, as novel biomarkers of dermatomyositis and potential metabolic drivers of the higher cancer incidence observed in this inflammatory myopathy.